GlassScriptPhysician profile
Joseph Daniel Cuomo
NPI 1336881143
$2,274.76
in general payments reported to CMS, 2019-2025
9 companies · $2,275 in 2025
The $2,275 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,142 · Travel and Lodging: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,141.69 |
| Travel and Lodging | $1,133.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,192.11 | 2025 | |
| Stryker Corporation | $302.14 | 2025 | Salvation, Ortholoc 2 Lapifuse, 7 X 23mm Citrelock Implant |
| Kerecis Limited | $275.86 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbvie INC. | $207.79 | 2025 | |
| Integra Lifesciences Corporation | $173.27 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biocomposites INC | $42.09 | 2025 | Stimulan |
| Paratek Pharmaceuticals, INC. | $30.52 | 2025 | Nuzyra |
| Bioventus LLC | $26.58 | 2025 | Exogen Ultrasound Bone Healing System |
| Melinta Therapeutics, LLC | $24.40 | 2025 | Orbactiv, Kimyrsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cuomo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.